Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAP-D
NCT06295120Phase 4Completed
- Sponsor
- Research Unit for General Practice in Aalborg
- Start
- Nov 2023
- Primary completion
- Mar 2026
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of phenoxymethylpenicillin in community acquired pneumonia (CAP), sponsored by Research Unit for General Practice in Aalborg. Started Nov 2023; status: completed.
02
Drugs
phenoxymethylpenicillin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT06295120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06295120.